-
Product Name
Tafasitamab (Synonyms: MOR-208; XMAB5574)
- Documents
-
Description
Anti-CD19 Antibody (Tafasitamab)
-
Tested applications
ELISA
-
Species reactivity
Human CD19
-
Alternative names
MOR-208 antibody; XMAB5574 antibody; XMAB-5574 antibody
-
Isotype
IgG1
-
Preparation
Recombinant expression and purified from CHO cells.
-
Clonality
Monoclonal
-
Formulation
25mM histidine, 8% sucrose, 0.01% Tween 80, pH6.2
-
Storage instructions
Upon receipt, store immediately at -20°C for 24 months in lypholized state. -80°C for 12 month after reconstitution. Avoid repeated freeze-thaw cycles.
-
Validations
SDS-PAGE
Anti-CD19 Antibody (tafasitamab) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
SEC-HPLC
The purity of Anti-CD19 Antibody (tafasitamab) is 98.59%, determined by SEC-HPLC.
Bioactivity: ELISA
Immobilized human CD19 (20 291) Protein, His Tag at 2 ug/mL can bind Anti-CD19 Antibody (tafasitamab), EC50=0.0904 ug/mL.
Bioactivity: FACS
Human CD19 HEK293 cells were stained with Anti-CD19 Antibody (tafasitamab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS, EC50=0.085 ug/mL.
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"